Quantcast

Latest Jean Deleage Stories

2011-11-02 13:00:00

Donation targeted for research into difficult challenges and obesity faced by those suffering from Prader-Willi Syndrome San Francisco and Los Angeles (PRWEB) November 02, 2011 The estate of Jean Joachim Deleage, together with the Foundation for Prader-Willi Research (FPWR), today jointly announced a donation of $500,000 made by the estate to further primary research into Prader-Willi Syndrome, a childhood disease that has painful and devastating effects from birth, through childhood and...

2011-03-14 07:35:00

BEDMINSTER, N.J., March 14, 2011 /PRNewswire/ -- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms. Existing investor, Sofinnova Partners, also participated in the financing. The capital raised will be used to fund the Phase 3 clinical development of Omthera's novel...

2010-09-08 07:10:00

MENLO PARK, Calif., Sept. 8 /PRNewswire/ -- Sofinnova Ventures, a venture capital firm based in Silicon Valley, today announced that Garheng Kong, M.D., Ph.D. has joined the firm as General Partner. He will actively invest in biopharmaceutical companies from the firm's current fund, SVP VII. Up until joining Sofinnova, Kong was a General Partner at Intersouth Partners, where he has been for the past ten years. He was the founding investor of Cellective Therapeutics, a Sofinnova Ventures...

2009-06-22 16:52:00

Funding of Stroke Company Exemplifies Firm's Strategy in the Field of Medical Device PARIS and MINNEAPOLIS, June 22 /PRNewswire/ -- Sofinnova Partners of Paris, France today announced having led a $21.5M financing in Minneapolis based medical device company CoAxia. The round also included participation from previous major investors Affinity Capital Management, Baird Venture Partners, Canaan Ventures Partners, Johnson and Johnson Development Corporation, and Prism Ventureworks. CoAxia is a...

2009-04-10 06:00:00

Company to Advance Ganaxolone Program for the Treatment of Epilepsy BRANFORD, Conn., April 10 /PRNewswire/ -- Marinus Pharmaceuticals, Inc., a developer of drugs to treat serious neurological and psychiatric disorders, today announced the close of a $20 million Series B financing. The funding comes on the heels of the Company's recent announcement of positive Phase 2a data for ganaxolone as an adjunctive therapy in adults with partial onset seizures. The Series B financing included...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.